Paramesu Biotech Ltd. IPO Details
Paramesu Biotech was incorporated on September 7, 2011. The company is one of the largest manufacturers of maize-based specialty products in India. It offers a diverse range of products, including native maize starch, modified starches, liquid glucose, maltodextrin, and co-products like germ, gluten, and fiber
| Bidding Dates |
|---|
| To Be Announced |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price Band | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 0 | - | - | ₹6,000.0 M | DRHP DOC |
Paramesu Biotech issue details
Paramesu Biotech IPO issue size is ₹ 6,000.0 M
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 35% | 15% | 50% |
Paramesu Biotech IMPORTANT IPO DATES
| Issue Open Date | - |
| Issue close Date | - |
| Allotment Date | - |
| Refund Date | - |
| Demat Account Credit Date | - |
| Listing Date | - |
| Listing on Exchange(s) | NSE and BSE |
Paramesu Biotech NUMBER OF SHARES ON OFFER
Paramesu Biotech FINANCIALS
| Period | Net Profit (Rs in millions) | Revenue from Operations (Rs in millions) | Cash Flow from Operations (Rs in millions) | Free Cash Flow (Rs in millions) | Margins |
| H1FY25 | 268.5 | 4,075.9 | 490.3 | 365.0 | 12.4% |
| FY24 | 403.4 | 6,278.5 | 321.8 | -480.9 | 12.2% |
| FY23 | 325.2 | 6,239.3 | 151.3 | -506.8 | 9.1% |
| FY22 | 339.7 | 4,949.1 | 831.8 | 781.4 | 12.1% |
Paramesu Biotech INFORMATION ON IPO ISSUE
About Paramesu Biotech
Paramesu Biotech was incorporated on September 7, 2011. The company is one of the largest manufacturers of maize-based specialty products in India. It offers a diverse range of products, including native maize starch, modified starches, liquid glucose, maltodextrin, and co-products like germ, gluten, and fiber
Object of the Issue
- Funding the capital expenditure requirement for setting up of new plant of 1200 TPD at the proposed facility in Mohasa – Babai, District Narmadapuram, Madhya Pradesh
- Repayment and/ or pre-payment, in part or full, of certain borrowings availed by the company
- General corporate purposes
Paramesu Biotech - PROMOTERS
| Name |
|---|
| Ananda Swaroop Adavani |
| Mani Swetha Tetali |
| Himabindu Tetali |
| Unimark Business Solutions Private Limited |
Paramesu Biotech Book Running Lead Manager
Pantomath Capital Advisors Private Limited
paramesu.ipo@pantomathgroup.com
Paramesu Biotech Registrar to the Offer
Bigshare Services Private Limited
ipo@bigshareonline.com
Paramesu Biotech Strengths
Diversified customer base
The company is one of the few companies in the country specializing in various types of modified starches (Source: F&S Report). These products are crucial in many industries, serving as ingredients, stabilizers, sweeteners, emulsifiers, additives, and more
Strategically located manufacturing plant
The company has a strategically located manufacturing plant, well-connected to raw material sources and key consumption markets
Well positioned to tap growing opportunities
The company's established market position reflects vast experience, large capacities, and strong customer relationships, enabling it to capitalize on opportunities in both existing and future products.
Paramesu Biotech Risks
Dependent on raw material suppliers
While the company has long-standing relationships with suppliers, it has not secured long-term contracts for raw materials. Increases in material costs, shortages, or challenges in supplier relationships could negatively impact business and operations
Reduced demand
The company sells products for specific uses across various industries, but any reduction in demand from these industries could lead to a loss of business and negatively impact financial performance and condition
Dependent on repeat customers
As of September 30, 2024, the company derives 89.4% of its revenue from orders placed by repeat customers. Any loss of, or a significant reduction in repeat customers could adversely affect the business, results of operations, financial condition, and cash flows
IPO FAQs
The promoters of the company are Ananda Swaroop Adavani, Mani Swetha Tetali, Himabindu Tetali and Unimark Business Solutions Private Limited.
The category allocation of qualified institutional buyers is 50.0%, the category allocation of non individual investors or high networth individuals is 15.0% and for retail investors it is 35.0%.